Internal Medicine, Endocrinology, Diabetes, & Metabolism · Corpus Christi, TX
NPI
1851378863
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1521 S Staples St, Suite 801
Corpus Christi, TX, 78404
Phone (361) 888-5794
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
1,215 services
Medicare patients, 2024
490
Average age 73
Drug cost, 2024
$4.0M
13,459 prescriptions
Company payments, 2025
$1,531
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacqueline E Cohn was code 99213 (office e&m - established), 764 times for 340 patients. In total Jacqueline E Cohn billed 1,215 services in 11 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 764 | 340 | $56.54 | $43K |
| 99214 Office E&M - Established | Office | 373 | 174 | $89.10 | $33K |
| 99204 Office E&M - New | Office | 19 | 19 | $114.83 | $2,182 |
By year: 2022 $84K for 1,318 services; 2023 $81K for 1,281 services; 2024 $79K for 1,215 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jacqueline E Cohn prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,351 prescriptions and refills. In total Jacqueline E Cohn wrote 13,459 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,351 | 5,809 | 573 | $24K |
| Ozempic Semaglutide | 579 | 766 | 109 | $649K |
| Mounjaro Tirzepatide | 492 | 561 | 82 | $586K |
| Synthroid Levothyroxine Sodium | 482 | 1,126 | 117 | $39K |
| Metformin Hcl Generic | 335 | 819 | 88 | $2,485 |
| Atorvastatin Calcium Generic | 314 | 908 | 89 | $3,048 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 282 | 538 | 76 | $48K |
| Metformin Hcl Er Metformin Hcl | 263 | 709 | 74 | $2,433 |
| Jardiance Empagliflozin | 252 | 440 | 54 | $253K |
| Humalog Kwikpen U-100 Insulin Lispro | 239 | 489 | 73 | $93K |
| Glimepiride Generic | 239 | 622 | 60 | $2,549 |
| Rosuvastatin Calcium Generic | 236 | 633 | 64 | $2,911 |
| Simvastatin Generic | 177 | 499 | 52 | $1,821 |
| Losartan Potassium Generic | 175 | 498 | 56 | $2,135 |
| Methimazole Generic | 173 | 391 | 44 | $1,843 |
Brand drugs: 5,440 claims; generic drugs: 7,265 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacqueline E Cohn $1,531 ($1,531 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novo Nordisk Inc with $347.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 22 | $347 |
| Mannkind Corporation MNKD | 11 | $271 |
| Ascendis Pharma Endocrinology Inc ASND | 7 | $199 |
| Abbvie Inc. ABBV | 4 | $75.04 |
| Corcept Therapeutics CORT | 3 | $69.35 |
| Insulet Corporation PODD | 3 | $63.39 |
| Rhythm Pharmaceuticals, Inc. RYTM | 2 | $55.18 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $49.62 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $48.69 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $42.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.